In 2023, Shehab-Eldeen et al. [133] demonstrated that the serum expression levels of Linc00152 and UCA1 were significantly higher in patients with HCC than those with liver cirrhosis or healthy subjects. The gene discussed is CYTOR; the disease is hepatocellular carcinoma.